期刊文献+

磷酸二酯酶5(PDE5)在人增生前列腺移行带中的表达及分布 被引量:1

Expression and Distribution of Phosphodiesterase type 5(PDE5) in the Transitional Zone of Benign Prostatic Hyperplasia
原文传递
导出
摘要 目的:探讨磷酸二酯酶5在人前列腺移行带组织中的表达与分布。方法:应用免疫组化SP法,选择前列腺增生患者34例,检测PDE5表达及分布。结果:34例标本中PDE5均呈阳性表达。PDE5在前列腺移行带的腺组织上皮普遍呈中等表达,间质部分弱表达。结论:PDE5在人增生前列腺组织中分布,但分布不均,表明不同PDE5可能行使不同的功能。 Objective: To investigate the Expression and Distribution of Phosphodiesterase 5 (PDE5) in the transitional zone of Benign Prostatic Hyperplasia. Methods: The immunohistochemical SP method was used to detect the expression 'of PDE5 in the transi- tional zone of Benign Prostatic Hyperplasia. Results: All sections were immunopositive for PDE5. The immnuointensity of PDE 5 was relatively moderate in the epithelium of glandular structures. In contrast, PDE5 showed immunoactivity in the fibromuscular stroma but its immnuointensity was faint. Conclusion: PDE5 is widely distributed in the transitional zone of Benign Prostatic Hyperplasia, but the distri- bution is not even, indicating that different PDE5 may execute the different functions.
出处 《现代生物医学进展》 CAS 2012年第18期3538-3540,共3页 Progress in Modern Biomedicine
基金 浦东新区科技发展基金创新资金(PKJ2009-Y-29)
关键词 磷酸二酯酶5 前列腺增生 免疫组化 Phosphodiesterase 5 Benign Prostatic Hyperplasia Immunohistochemistry
  • 相关文献

参考文献21

  • 1Emberton M, Zinner N, Michel MC, et al. Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: thera- peutic options for the man at risk[J]. BJU Int, 2007, 100:249-253.
  • 2Lu-Yao GL, Barry MJ, Chang CH, et al. Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes[J]. Urology, 1994,44:692-699.
  • 3Smet PJ, Jonavicius J, Marshall VR, et al. Distribution of nitric oxide synthase-immunoreactive nerves and identifi cation of the cellular tar- gets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry[J]. Neuroseienee, 1996, 71:337-348.
  • 4Bustamante S, Orensanz LM, Recio P, et al. Funetional evidence ofnit- rergic neurotransmission in the human urinary bladder neck [J]. Neu- rosci Lett, 2010, 477:91-94.
  • 5Takeda M, Tang R, Shapiro E, et al. Effects of nitric oxide on human and canine prostates[J]. Urology, 1995,45:440-446.
  • 6Yoshimura N, Seki S, De Groat WC. Nitric oxide modulates Ca (2+) channels in dorsal root anglion neurons innervating rat urinary bladder [J]. J Neurophysiol, 2001, 86:304-311.
  • 7Kawano T, Zoga V, Kimura M, et al. Nitric oxide activates ATP-sensi- tive potassium channels in mammalian sensory neurons: action by di- rect S-nitrosylation[J]. Mol Pain, 2009, 5:12.
  • 8Yoshimura N, Seki S, Chancellor MB, et al. Targeting afferent hyper- excitability for therapy of the painfut bladder syndrome [J]. Urotogy, 2002, 59 ( Suppl. 1 ): 61-67.
  • 9Kedia GT, Uekert S, Jonas U, et ai. The nitric oxide pathway in the hu- man prostate: clinical implications in men with lower urinary tract symptoms[J]. World J Urol, 2008, 26:603-609.
  • 10Hedlund P. Nitric oxidegcGMP-mediated effects in the outflow re- gion of the lower urinary tract - is there a basis for pharmacological targeting of cGMP?[J]. World J Urol, 2005, 23:362-367.

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部